There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type ...

nebulizer therapy may be more affordable than the use of pMDI and DPI devices for many elderly patients with COPD. Medication availability issues and inhaler device convenience features can be key ...

In conclusion, the Easyhaler ® more closely demonstrates the characteristics of an ‘ideal inhaler' than its competitors ... budesonide in a DPI to children whose inspiration rates will be ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could ...

Inhaler: peak plasma concentrations of 49ng/mL reached within 15 minutes. Nasal spray: maximum venous concentrations of 2–12ng/mL reached in 4–15 minutes. Nasal Spray antagonized by nasal ...

Pharmaceutical companies are looking to change that with lower-emitting inhalers that they plan to roll out by the end of the decade. Metered-dose inhalers - pressurized devices that release a ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and ...

Members of the HELP Committee are criticizing drugmakers for charging more for inhalers in the U.S. than in other countries. Improving the Patient Financial Experience Throughout the Patient Journey ...

Some people use their inhaler on a daily basis while others may only need it for emergency relief, such as during an asthma attack. Here's what you need to know about how long inhalers last and ...

Inhaler have teased their upcoming album on social media in the form of a video collage of them in the studio. READ MORE: The NME Big Read – Inhaler: “We’re not here to be a mid-bill ...

Inhaler have spoken to NME about their energetic new single ‘Your House’ and the process of creating their upcoming third album album ‘Open Wide’. READ MORE: Inhaler on the cover: “We ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...